108 related articles for article (PubMed ID: 2112958)
1. Enhanced production of tissue-type plasminogen activator by estradiol in a novel type variant of human breast cancer MCF-7 cell line.
Mizoguchi H; Uchiumi T; Ono M; Kohno K; Kuwano M
Biochim Biophys Acta; 1990 May; 1052(3):475-82. PubMed ID: 2112958
[TBL] [Abstract][Full Text] [Related]
2. Counteraction of estradiol-induced activation of tissue-type plasminogen activator in a human breast cancer cell line by an anti-estrogen, LY117018.
Uchiumi T; Mizoguchi H; Hagino Y; Kohno K; Kuwano M
Int J Cancer; 1991 Jan; 47(1):80-5. PubMed ID: 1702405
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activators in human breast cancer cell lines: hormonal regulation and properties.
Mangel WF; Toledo DL; Nardulli AM; Reiner GC; Norman MJ; Katzenellenbogen BS
J Steroid Biochem; 1988; 30(1-6):79-88. PubMed ID: 3386280
[TBL] [Abstract][Full Text] [Related]
4. Estrogen regulation of human breast cancer cell line MCF-7 tissue plasminogen activator.
Dickerman HW; Martinez HL; Seeger JI; Kumar SA
Endocrinology; 1989 Jul; 125(1):492-500. PubMed ID: 2500332
[TBL] [Abstract][Full Text] [Related]
5. Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Gierthy JF; Lincoln DW; Gillespie MB; Seeger JI; Martinez HL; Dickerman HW; Kumar SA
Cancer Res; 1987 Dec; 47(23):6198-203. PubMed ID: 3119194
[TBL] [Abstract][Full Text] [Related]
6. Estrogen inhibits the growth of MCF-7 cell variants resistant to transforming growth factor-beta.
Hagino Y; Mawatari M; Yoshimura A; Kohno K; Kobayashi M; Kuwano M
Jpn J Cancer Res; 1988 Jan; 79(1):74-81. PubMed ID: 3128508
[TBL] [Abstract][Full Text] [Related]
7. Laminin and estradiol regulation of the plasminogen-activator system in MCF-7 breast-carcinoma cells.
Sonohara S; Mira-y-Lopez R; Brentani MM
Int J Cancer; 1998 Mar; 76(1):77-85. PubMed ID: 9533765
[TBL] [Abstract][Full Text] [Related]
8. Estradiol preferentially enhances extracellular tissue plasminogen activators of MCF-7 breast cancer cells.
Ryan TJ; Seeger JI; Kumar SA; Dickerman HW
J Biol Chem; 1984 Dec; 259(23):14324-7. PubMed ID: 6542103
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1.
Casslén B; Sandberg T; Gustavsson B; Willén R; Nilbert M
Biol Reprod; 1998 Jun; 58(6):1343-50. PubMed ID: 9623591
[TBL] [Abstract][Full Text] [Related]
10. Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231.
Pourreau-Schneider N; Delori P; Boutière B; Arnoux D; George F; Sampol J; Martin PM
J Natl Cancer Inst; 1989 Feb; 81(4):259-66. PubMed ID: 2492346
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
12. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells.
Biegel L; Safe S
J Steroid Biochem Mol Biol; 1990 Dec; 37(5):725-32. PubMed ID: 2278856
[TBL] [Abstract][Full Text] [Related]
13. Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy.
Mira-y-Lopez R; Osborne MP; DePalo AJ; Ossowski L
Int J Cancer; 1991 Apr; 47(6):827-32. PubMed ID: 1901298
[TBL] [Abstract][Full Text] [Related]
14. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
15. Calcium spirulan as an inducer of tissue-type plasminogen activator in human fetal lung fibroblasts.
Hayakawa Y; Hayashi T; Hayashi K; Ozawa T; Niiya K; Sakuragawa N
Biochim Biophys Acta; 1997 Mar; 1355(3):241-7. PubMed ID: 9060995
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
17. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
Koutsilieris M; Frenette G; Lazure C; Lehoux JG; Govindan MV; Polychronakos C
Anticancer Res; 1993; 13(2):481-6. PubMed ID: 7685989
[TBL] [Abstract][Full Text] [Related]
18. Specific stimulation by estradiol of tissue-type plasminogen activator production in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.
Yamashita J; Inada K; Yamashita S; Matsuo S; Nakashima Y; Ogawa M
Horm Metab Res; 1992 Dec; 24(12):565-9. PubMed ID: 1478614
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC
Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells.
Fukao H; Ueshima S; Takaishi T; Okada K; Matsuo O
Biochim Biophys Acta; 1997 Mar; 1356(1):111-20. PubMed ID: 9099997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
